Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Zhejiang Runyang New Material Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥16.12 |
52 Week High | CN¥22.39 |
52 Week Low | CN¥9.81 |
Beta | 0.61 |
1 Month Change | 18.62% |
3 Month Change | -22.80% |
1 Year Change | -6.87% |
3 Year Change | -65.18% |
5 Year Change | n/a |
Change since IPO | -64.07% |
Recent News & Updates
Shareholder Returns
300920 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 4.1% | 4.0% | 0.9% |
1Y | -6.9% | -22.3% | -16.5% |
Rentabilidad frente al sector: 300920 superó al sector CN Chemicals , que obtuvo un rendimiento del -35.7% el año pasado.
Rentabilidad vs. Mercado: 300920 superó al mercado CN, que obtuvo un rendimiento del -16.6% el año pasado.
Price Volatility
300920 volatility | |
---|---|
300920 Average Weekly Movement | 11.2% |
Chemicals Industry Average Movement | 8.2% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 11.6% |
10% least volatile stocks in CN Market | 5.2% |
Precio estable de las acciones: 300920ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: 300920La volatilidad semanal ha pasado de 6% a 11% en el último año.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 657 | n/a | https://www.zj-runyang.com |
Zhejiang Runyang New Material Technology Co., Ltd. se dedica a la investigación y el desarrollo, la producción y la venta de materiales de espuma de poliolefina en China y a escala internacional. Ofrece polietileno reticulado por irradiación de electrones (IXPE), que incluye series mejoradas antibacterianas, series populares y series especiales.
Zhejiang Runyang New Material Technology Co., Ltd. Fundamentals Summary
300920 fundamental statistics | |
---|---|
Market cap | CN¥1.61b |
Earnings (TTM) | CN¥32.19m |
Revenue (TTM) | CN¥323.96m |
50.1x
P/E Ratio5.0x
P/S RatioIs 300920 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300920 income statement (TTM) | |
---|---|
Revenue | CN¥323.96m |
Cost of Revenue | CN¥266.39m |
Gross Profit | CN¥57.57m |
Other Expenses | CN¥25.37m |
Earnings | CN¥32.19m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 22, 2024
Earnings per share (EPS) | 0.32 |
Gross Margin | 17.77% |
Net Profit Margin | 9.94% |
Debt/Equity Ratio | 5.7% |
How did 300920 perform over the long term?
See historical performance and comparison